glp 1 and histamine intolerance MCAS & intolerance: the GLP-1 connection nobody’s talking about…., New research is showing something wild: in a case series of MCAS patients, 89% saw real symptom relief after starting a Histamine Intolerance After 40: Why

Participants were randomized to either continue the medication or switch to a placebo for another 52 weeks

Evidence for glucagon-like peptide-1 receptor signaling to activate ATP-sensitive potassium channels in pancreatic beta cells

Specifically, the progressive loss of behavioral control, manifested by persistent overconsumption despite adverse consequences, mirrors the sustained positive energy balance that underlies and perpetuates weight gain (O'Connor and Kenny, 2022

Arms and thighs may still feel like problem areas even after significant weight loss

Boehringer Ingelheim International GmbH (Emerging Leader) is classified as a rapidly emerging leader, with a focus on developing a novel GLP-1 agonist (Survodutide) in phase 3 of clinical development